Finance
EnteroBiotix Completes £27m Financing Round & Initiates Phase 2 Study in Patients with IBS
EnteroBiotix Limited, a clinical-stage biotechnology company focussed on developing best-in-class full-spectrum microbiome therapeutics, today announced that the Company has completed its £27m ($34m USD) funding round, supported by new and existing investors. The funding will […]